Is India Winning the War Against Rising Non-Communicable Diseases? The latest health statistics paint a concerning picture: diabetes, heart disease, and cancer rates are climbing, impacting millions across the country. From rural healthcare access to the burgeoning urban health crisis, challenges remain significant. This week, we delve into the crucial initiatives underway – government policies, technological advancements in telemedicine, and the rising role of preventative healthcare – that aim to address this national health emergency. Experts weigh in on the effectiveness of current strategies and the critical need for increased public awareness campaigns targeting lifestyle diseases. Are these efforts enough? Explore Abtak.com's in-depth coverage on healthcare in India and discover the vital information you need to protect your well-being and the future of public health. Stay informed; stay healthy.
NEW DELHI, Apr 1: The GLP-1 based weight loss drugs are prescription medications used to treat type 2 diabetes and obesity but carry serious side effects and must only be taken under the supervision of a qualified medical specialist, the government said on Wednesday. Highlighting that multiple variants of GLP-1 drugs have been recently introduced in the Indian market, and concerns have emerged regarding their on-demand availability through retail pharmacies, online platforms, wholesalers, and wellness clinics, the government said the CDSCO has intensified its regulatory surveillance against its unauthorised sale and promotion and warned stricter inspections and surveillance will continue in the coming weeks.
New Delhi [India], July 16 (ANI): The Indian government expressed regret on Tuesday over the reported demolition of the ancestral property of celebrated filmmaker and writer Satyajit Ray in Mymensingh, Bangladesh and expressed its willingness to extend cooperation in its restoration. "We note with profound regret that the ancestral property of noted filmmaker and litterateur Satyajit Ray in Mymensingh, Bangladesh, belonging to his grandfather and eminent litterateur, Upendra Kishor Ray Chowdhury, is being demolished," the Ministry of External Affairs said. Also Read | India Urges Bangladesh ...Read More >
Hyderabad: Overdependence on white rice, refined grains and added sugars is fuelling a surge in diabetes and obesity among Indians, according to an ICMR-INDIAB survey. Telangana reflects the same dietary risks as the rest of the country. The study, published in Nature Medicine, found that more than 62 per cent of daily calories in Indian diets come from low-quality carbohydrates, while protein intake remains low and saturated fat consumption exceeds recommended levels in most states. In Telangana, high reliance on refined cereals and inadequate protein has been linked to an elevated risk of t ...Read More >
Bengaluru: Biocon Limited has achieved a regulatory milestone in the United States, reinforcing its presence in the global diabetes treatment market. Biocon Pharma Limited, a subsidiary of Biocon Limited, has received approval from the U.S. Food and Drug Administration for Dapagliflozin Tablets in 5 mg and 10 mg strengths. The approval enables the company to market the drug for adults with type 2 diabetes mellitus, expanding its footprint in one of the world's largest pharmaceutical markets. The approved drug is indicated as an adjunct to diet and exercise to improve glycemic control in adul ...Read More >
NEW DELHI: Amid continued violations and the widespread misuse and easy availability of weight loss drugs in the market, the Centre on Wednesday warned that those who break the rules "will face licence cancellation, fines and legal action." In a detailed note on GLP 1 drugs, their use, risks and regulation, the Centre said multiple variants of weight loss drugs have recently been introduced in the Indian market, raising concerns over their on demand availability through retail pharmacies, online platforms, wholesalers and wellness clinics. To prevent unauthorised sale, unsupervised use and o ...Read More >
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. Also Read | Indian Railways Carries 1,670 MT Freight, Runs 25,000 Trains Daily in Financial Year 2026. According to the Official sources, the IPC has started the regular monitoring of adverse events ...Read More >
New Delhi, Jul 2 (PTI) The Delhi High Court on Wednesday asked the Drug Controller General of India to consult experts and relevant stakeholders in deciding a plea over drug combinations sold in the market for weight loss treatment. A bench of Chief Justice D K Upadhyaya and Justice Tushar Rao Gedela asked the petitioner to give a representation to the DGCI, which was asked to decide the matter within three months. Also Read | 'Janaki' Title Row: Malayalam Film Industry Holds Protest in Front of CBFC Office Against Renaming of Suresh Gopi Film. A plea filed by Jitendra Chouksey said license ...Read More >
New Delhi, July 14 (SocialNews.XYZ) Dietary approaches like intermittent energy restriction, time-restricted eating, and continuous energy restriction can all improve blood sugar levels and body weight in people with obesity and type 2 diabetes, according to a study. Although researchers identified improved HbA1c levels, and adverse events were similar across the three groups, the IER group showed greater advantages in reducing fasting blood glucose, improving insulin sensitivity, lowering triglycerides, and strengthening adherence to the dietary interventions. IER typically involves periods ...Read More >
Mumbai (Maharashtra) [India], November 3: Echosens, the leader in non-invasive liver diagnostics, today announced the opening of its new regional headquarters* in Mumbai, India. The new office in the Bandra Kurla Complex (BKC) will serve as the company's hub for operations across South Asia, expanding access to FibroScan® in India, Bangladesh, Bhutan, The Maldives, Nepal, and Sri Lanka. Also Read | 'Pakistan's Been Testing': US President Donald Trump Says Pakistan 'Testing' Nuclear Weapons, Defends US' Decision To Resume Testing (Watch Video). Echosens has been present in India for more than ...Read More >
A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40-50% post patent expiry. Three early movers are taking sharply different routes -- low-cost, premium, and partnerships in a high-stakes land grab. The Indian market for Glucagon-Like Peptide-1 (GLP-1) therapies is currently at an inflection point and is poised for strong expansion. The current market size for anti-obesity and diabetes GLP-1 drugs in India, as of 2025, is estimated to be between ₹1,000-1,200 cr ...Read More >
New Delhi, Jul 3 (PTI) Adopting a healthier lifestyle is more effective than using the anti-diabetes drug metformin, with the benefits persisting over 20 years later, according to a study. The US Diabetes Prevention Program, launched in 1996, enrolled 3,234 patients with prediabetes from 30 institutions across 22 states. The study aimed to compare the benefits of metformin and a lifestyle modification that included exercise and a healthy diet. Researchers from The University of New Mexico, US, found that making lifestyle changes lowered the development of diabetes by 24 per cent, while the a ...Read More >
Mumbai: Less than a month after Ozempic maker Novo Nordisk announced it is cutting its global workforce as part of a restructuring plan, the layoffs have hit Indian employees in Bengaluru. Junior- to mid-level employees across functions such as sales and marketing, as well as those in the company's global business services (GBS) hub, which works with its global teams, have been impacted, according to at least three people aware of the development. "At least 100-150 will be retrenched from the commercial unit, which largely includes sales and marketing roles. They are expected to be in junior ...Read More >
New Delhi [India], April 1 (ANI): The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release. Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar. If left untreated, it can lead to complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation. Insulin and glucagon are hormones produced by the pancreas that regulate blood sugar (glucose) levels. I ...Read More >
Bangalore : Emcure Pharmaceuticals Ltd., (BSE: 544210, NSE: EMCURE) has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses). The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple administration and precise dosing. As the first Indian company to exclusively distribute and commercialis ...Read More >
HYDERABAD, India, April 3 (Reuters) - Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India. New Delhi wellness clinic Klarity Skin Clinic touts a "Mounjaro bride" package, while other clinics have woven weight-loss injections into "pre-wedding" transformation packages typically focused on skin treatments and hairstyle makeovers. In a social media video, Klarity offers "guided nutrition, Mounjaro and smart workouts" to prepare brides to walk down the aisle. The clinic did not respond to a reques ...Read More >
New Delhi [India], August 25 (ANI): India's contract research, development, and manufacturing organisation (CRDMO) sector is emerging as one of the most dynamic growth stories in the global pharmaceutical landscape. According to a recent Jefferies India report, the country's CRDMO, which has already reached revenues of around USD 3 billion, has grown at a compound annual growth rate (CAGR) of 14 per cent over the past five years. The report highlights that India's CRDMO industry has caught the attention of global investors, with its market capitalization now standing at USD 40-50 billion. Whi ...Read More >
New Delhi [India], September 30 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has approved Danish drugmaker Novo Nordisk's once-a-week injection for patients suffering from Type 2 diabetes. Also Read | Durga Puja 2025: PM Narendra Modi Participates in Durga Puja Celebrations in Delhi's CR Park on Occasion of Maha Ashtami, Prays for Everyone's Happiness and Wellbeing (See Pics). In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals with Type 2 diabetes and will be available only upon a doctor's prescription. "Ozempic is meant for pe ...Read More >
New Delhi, Dec 15 (PTI) Biocon Ltd on Monday said it has launched its diabetes and chronic weight management injection, Liraglutide, in the Netherlands through its distribution partner, Pharmamedic BV. The drug-device combination will be marketed in the Netherlands under the brand names Diavorin for diabetes and Vobexoryn for chronic weight management, Biocon said in a statement. Liraglutide is a synthetic analog of GLP-1 peptide (glucagon-like peptide-1) that helps lower blood sugar levels and promote weight loss. It is administered as a once-daily injection, the company said. The launch f ...Read More >
New Delhi [India], April 1 (ANI): The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release. Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar. If left untreated, it can lead to complications like blindness, kidney failure, heart attacks, stroke and lower limb amputation. Also Read | Patna Shocker: Woman Drugged With Sedative-Laced Drink and Gang-Raped on Pretext of Job Prom ...Read More >
MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker ha ...Read More >
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular weight-loss drug Wegovy over fears of falling behind rival Eli Lilly in the potentially huge market, two sources familiar with the plans told Reuters. Officials at the Danish drugmaker have said Wegovy might be introduced in India in 2026 once regulatory approvals are in hand and there is sufficient supply. More recently, Novo's India team proposed moving the launch to next year, around the same time Lilly is expected to introduce its weight-loss drug Mounjaro. In a clo ...Read More >
Mumbai (Maharashtra) [India], July 14 (ANI): Shiv Sena MP Milind Deora and chair of Parliamentary Committee on Subordinate Legislation on Monday said India should regulate unhealthy foods sold by multinational companies, along with Indian snacks such as jalebis and samosas, to deal with rising obesity problems. The Union health ministry has recently proposed displaying sugar and oil boards as an initiative to promote healthier dietary habits in various settings. According to the ministry's proposal, these boards will serve as visual behavioural nudges in schools, offices, public institutions e ...Read More >
India Diabetes Market: By Type; By Treatment Type; By Doses Form; Route of Administration; By End User; By Distribution Channel; Supplier Landscape; 2025-2034 The India diabetes market attained a value of approximately INR 316.00 Billion in 2024. The market is projected to grow at a compound annual growth rate (CAGR) of 16.00% during the forecast period of 2025-2034, reaching an estimated value of around INR 1394.01 Billion by 2034. The rising prevalence of diabetes, driven by sedentary lifestyles, changing dietary habits, and increasing obesity rates, is contributing significantly to the mar ...Read More >
Mumbai : As the world celebrates pharmacists today, Zeno Health reveals the quiet truth about who India really trusts when it comes to their health. Based on a survey of over 500 pharmacists across Mumbai, Pune, and Nashik, the report shows that, beyond doctors, pharmacists stand at the intersection of trust, clarity, and affordability. This year's global theme by the International Pharmaceutical Federation (FIP) "Think Health, Think Pharmacist", couldn't be more timely. In a country where chronic conditions are rising and out-of-pocket expenses remain high, pharmacists are becoming more than ...Read More >
Lucknow: Senior Samajwadi Party leader and former minister Gayatri Prajapati was attacked by a fellow inmate inside Lucknow Jail on Tuesday. The scuffle took place within the jail premises, after which prison authorities launched an internal inquiry. According to a statement issued by Dr Ramdhani, DIG Prisons, Lucknow Range, the incident occurred after Prajapati allegedly used abusive language towards another inmate, Vishwas Rajput. In response, Vishwas attacked Prajapati using a sharp object inside the cell. DIG Prisons clarified that the incident was not premeditated and dismissed any spec ...Read More >
READ MORE: Ozempic-maker's new fat-busting drug cuts body weight by a quarter - and it comes as a jab or a PILL The Ozempic boom has seen a drug widely used to treat diabetes and manage obesity in adults transform into 'miracle' weight loss jab that's coveted by anyone with a few extra kilos to shed. Ozempic and other alternatives like Mounjaro and Wegovy are all different brand names for the drug semaglutide that mimics the the actions of GLP-1 - a hormone in the brain that regulates appetite ...Read More >
New Delhi, Jul 2 (PTI) The Delhi High Court on Wednesday asked the Drug Controller General of India to consult experts and relevant stakeholders in deciding a plea over drug combinations sold in the market for weight loss treatment. A bench of Chief Justice D K Upadhyaya and Justice Tushar Rao Gedela asked the petitioner to give a representation to the DGCI, which was asked to decide the matter within three months. A plea filed by Jitendra Chouksey said licenses issued for the use and sale of such drugs were not based on adequate data. In an apparent reference to the recent death of popular ...Read More >
SCHOTT, a leader in specialty glass, initiates local production of high-precision glass tubing for syringes and cartridges in Gujarat, India. This marks a significant step in India's pharmaceutical sector, aligning with the 'Make in India' initiative, enhancing SCHOTT's role in the Asian market. In a notable development in India's pharmaceutical landscape, SCHOTT has successfully commenced local production of high-precision glass tubing for syringes and cartridges at its Jambusar, Gujarat facili ...Read More >
Indian brides are turning to low-cost weight-loss injections ahead of their weddings. Freepik ShowQuick Read Summary is AI-generated, newsroom-reviewed * Soon-to-be Indian brides and grooms increasingly seek weight-loss drugs before weddings * Mounjaro is preferred over Wegovy and prescribed only for medically eligible patients * Regulators warn against misuse amid cheaper local weight-loss drug versions flooding market Did our AI summary help? Let us know. Switch To Beeps Mode Soon-to- ...Read More >
Hyderabad: Managing prostate cancer cases in Hyderabad is becoming challenging as many patients are being diagnosed at advanced stages due to low levels of early screening. As per the data from Nizam's Institute of Medical Sciences (NIMS), prostate cancer accounts for 6.9 percent of all cancers among men in the city. By 2026, Telangana is expected to record over 21,252 new cancer cases in men, but less than 4 percent of people are currently undergoing screening. Unhealthy lifestyle habits such as obesity, smoking, and diets high in fat are contributing to the increase in cases. At the same ...Read More >
HYDERABAD, India, April 3 (Reuters) - Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India. New Delhi wellness clinic Klarity Skin Clinic touts a "Mounjaro bride" package, while other clinics have woven weight-loss injections into "pre-wedding" transformation packages typically focused on skin treatments and hairstyle makeovers. In a social media video, Klarity offers "guided nutrition, Mounjaro and smart workouts" to prepare brides to walk down the aisle. The clinic did not respond to a requ ...Read More >